BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 29858735)

  • 1. An Innovation for Treating Orthotopic Pancreatic Cancer by Preoperative Screening and Imaging-Guided Surgery.
    Han Z; Shang W; Liang X; Yan H; Hu M; Peng L; Jiang H; Fang C; Wang K; Tian J
    Mol Imaging Biol; 2019 Feb; 21(1):67-77. PubMed ID: 29858735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
    Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
    Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoacoustic and fluorescence image-guided surgery using a multifunctional targeted nanoprobe.
    Xi L; Zhou G; Gao N; Yang L; Gonzalo DA; Hughes SJ; Jiang H
    Ann Surg Oncol; 2014 May; 21(5):1602-9. PubMed ID: 24554061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.
    Christensen A; Juhl K; Persson M; Charabi BW; Mortensen J; Kiss K; Lelkaitis G; Rubek N; von Buchwald C; Kjær A
    Oncotarget; 2017 Feb; 8(9):15407-15419. PubMed ID: 28039488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery.
    Gutowski M; Framery B; Boonstra MC; Garambois V; Quenet F; Dumas K; Scherninski F; Cailler F; Vahrmeijer AL; Pèlegrin A
    Surg Oncol; 2017 Jun; 26(2):153-162. PubMed ID: 28577721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RGD-functionalised melanin nanoparticles for intraoperative photoacoustic imaging-guided breast cancer surgery.
    Liu JJ; Wang Z; Nie LM; Zhu YY; Li G; Lin LL; Chen M; Zhang GJ
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):847-860. PubMed ID: 34505945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of near-infrared (NIR) fluorescently labeled cetuximab as a potential tool for fluorescence-guided surgery.
    Saccomano M; Dullin C; Alves F; Napp J
    Int J Cancer; 2016 Nov; 139(10):2277-89. PubMed ID: 27428782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near Infrared Fluorescent Nanoparticles Derived from Hyaluronic Acid Improve Tumor Contrast for Image-Guided Surgery.
    Hill TK; Kelkar SS; Wojtynek NE; Souchek JJ; Payne WM; Stumpf K; Marini FC; Mohs AM
    Theranostics; 2016; 6(13):2314-2328. PubMed ID: 27877237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advantages of fluorescence-guided laparoscopic surgery of pancreatic cancer labeled with fluorescent anti-carcinoembryonic antigen antibodies in an orthotopic mouse model.
    Metildi CA; Kaushal S; Luiken GA; Hoffman RM; Bouvet M
    J Am Coll Surg; 2014 Jul; 219(1):132-41. PubMed ID: 24768506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
    Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
    Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
    [No Abstract]   [Full Text] [Related]  

  • 11. Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models.
    Zhang M; Kobayashi N; Zettlitz KA; Kono EA; Yamashiro JM; Tsai WK; Jiang ZK; Tran CP; Wang C; Guan J; Wu AM; Reiter RE
    Clin Cancer Res; 2019 Jan; 25(1):188-200. PubMed ID: 30301826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
    Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activatable Nanocomposite Probe for Preoperative Location and Intraoperative Navigation for Orthotopic Hepatic Tumor Resection via MSOT and Aggregation-Induced Near-IR-I/II Fluorescence Imaging.
    Zeng Z; Ouyang J; Sun L; Zeng C; Zeng F; Wu S
    Anal Chem; 2020 Jul; 92(13):9257-9264. PubMed ID: 32530263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immuno-OpenPET: a novel approach for early diagnosis and image-guided surgery for small resectable pancreatic cancer.
    Yoshii Y; Tashima H; Iwao Y; Yoshida E; Wakizaka H; Akamatsu G; Yamaya T; Matsumoto H; Yoshimoto M; Igarashi C; Hihara F; Tachibana T; Zhang MR; Nagatsu K; Sugyo A; Tsuji AB; Higashi T
    Sci Rep; 2020 Mar; 10(1):4143. PubMed ID: 32157106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ratiometric activatable cell-penetrating peptides label pancreatic cancer, enabling fluorescence-guided surgery, which reduces metastases and recurrence in orthotopic mouse models.
    Metildi CA; Felsen CN; Savariar EN; Nguyen QT; Kaushal S; Hoffman RM; Tsien RY; Bouvet M
    Ann Surg Oncol; 2015; 22(6):2082-7. PubMed ID: 25319581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic mouse models.
    Hiroshima Y; Maawy A; Zhang Y; Sato S; Murakami T; Yamamoto M; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    PLoS One; 2014; 9(6):e99977. PubMed ID: 24924955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Surgical Resection of Metastatic Liver Tumors With Near-Infrared Optical-Guided Fluorescence Imaging.
    Barabino G; Porcheron J; Cottier M; Cuilleron M; Coutard JG; Berger M; Molliex S; Beauchesne B; Phelip JM; Grichine A; Coll JL
    Surg Innov; 2016 Aug; 23(4):354-9. PubMed ID: 26603691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent.
    Hoogstins CES; Boogerd LSF; Sibinga Mulder BG; Mieog JSD; Swijnenburg RJ; van de Velde CJH; Farina Sarasqueta A; Bonsing BA; Framery B; Pèlegrin A; Gutowski M; Cailler F; Burggraaf J; Vahrmeijer AL
    Ann Surg Oncol; 2018 Oct; 25(11):3350-3357. PubMed ID: 30051369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-Modality ImmunoPET/Fluorescence Imaging of Prostate Cancer with an Anti-PSCA Cys-Minibody.
    Tsai WK; Zettlitz KA; Tavaré R; Kobayashi N; Reiter RE; Wu AM
    Theranostics; 2018; 8(21):5903-5914. PubMed ID: 30613270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near-infrared fluorescence imaging-guided surgery improves recurrence-free survival rate in novel orthotopic animal model of head and neck squamous cell carcinoma.
    Atallah I; Milet C; Henry M; Josserand V; Reyt E; Coll JL; Hurbin A; Righini CA
    Head Neck; 2016 Apr; 38 Suppl 1():E246-55. PubMed ID: 25546527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.